loading

Editas Medicine Inc Azioni (EDIT) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
23.19%
3.578
4.658 30.60 0.061 0.513
Operating Expenses
31.80%
55.12
80.82 77.20 65.73 72.42
Benefits Costs and Expenses
-
- - - -
Costs And Expenses
31.80%
55.12
80.82 77.20 65.73 72.42
Operating Income/Loss
32.32%
-51.54
-76.16 -46.59 -65.67 -71.90
Nonoperating Income/Loss
2,355%
-1.691
0.075 1.198 3.525 4.296
Income/Loss From Continuing Operations Before Tax
104.70%
3.578
-76.09 30.60 0.061 -67.61
Income/Loss From Continuing Operations After Tax
30.03%
-53.23
-76.09 -45.40 -62.14 -67.61
Net Income/Loss
30.03%
-53.23
-76.09 -45.40 -62.14 -67.61
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1.63%
84.41
83.06 0.0925 82.49 82.31
Diluted Average Shares
1.63%
84.41
83.06 0.0925 82.49 82.31
Basic Earnings Per Share
31.52%
-0.63
-0.92 -0.55 -0.75 -0.82
Diluted Earnings Per Share
31.52%
-0.63
-0.92 -0.55 -0.75 -0.82
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Capitalizzazione:     |  Volume (24 ore):